Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus-associated lymphoproliferative disorders.

D T Purtilo1, R S Strobach, M Okano

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|July 1, 1992
PubMed
Summary

Epstein-Barr virus (EBV)-induced lymphoproliferative disorders (LPD) pose risks for immunosuppressed individuals. Early detection using molecular methods aids in diagnosis and management, potentially preventing life-threatening conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathology of X-linked lymphoproliferative syndrome.

Immunology today·2014
Same author

Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Blood·2000
Same author

A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus.

Genomics·1997
Same author

Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly.

The Journal of clinical endocrinology and metabolism·1996
Same author

Molecular biology techniques in endocrinology.

Clinical endocrinology·1996
Same author

Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells.

Cancer research·1996

Area of Science:

  • Immunology
  • Virology
  • Pathology

Background:

  • Epstein-Barr virus (EBV) can cause lymphoproliferative disorders (LPD), particularly in immunosuppressed patients.
  • Immunocompromised individuals may not mount typical antibody responses to EBV, complicating diagnosis.
  • EBV-associated LPD is a significant concern, especially in patients with conditions like AIDS.

Purpose of the Study:

  • To provide an overview of the clinical, histopathologic, and molecular mechanisms of EBV-induced LPD in immunosuppressed individuals.
  • To highlight the importance of multiple diagnostic methods for EBV detection.
  • To discuss strategies for preventing and managing EBV-induced LPD.

Main Methods:

  • Review of clinical, histopathologic, and molecular biologic mechanisms.

Related Experiment Videos

  • Emphasis on diagnostic methods for EBV genome detection (e.g., molecular hybridization, immunofluorescence).
  • Distinguishing EBV-LPD from other conditions like hepatic allograft rejection.

    • Main Results:

    • Recognized high-risk immunocompromised populations for EBV-LPD.
    • Developed techniques for detecting EBV genome and early LPD.
    • Established methods to differentiate EBV-LPD from hepatic allograft rejection using histopathology and EBNA staining.

    Conclusions:

    • Early detection of EBV genome and LPD is crucial for managing immunosuppressed patients.
    • Combining histopathologic features with molecular techniques provides a solid diagnostic approach.
    • Further research into EBV vaccines and antiviral therapies is needed, especially for high-risk groups.